2 assets in Nijmegen Breakage Syndrome

Therapeutic assets addressing Nijmegen Breakage Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Olaparib Nijmegen Breakage Syndrome	Beth Israel Deaconess Medical Center	P2	CCC (53)
Treosulfan Nijmegen Breakage Syndrome	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2	CCC (53)